Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial.

Katja Vu Bartholdy,Niklas Dyrby Johansen,Nino Landler,Kristoffer Grundtvig Skaarup,Jesper Jensen,Iain Bressendorff,Morten Schou,Jacob Christensen,Bo Feldt-Rasmussen,Muthiah Vaduganathan,Scott Solomon,Richard Haynes,Frederik Persson,Peter Rossing,Lars Køber,Faiez Zannad,Ditte Hansen,Tor Biering-Sørensen

Kidney360（2023）

引用 0|浏览28

暂无评分

摘要

This is the first study to address the effects of SGLT2 inhibitors on cardiac structure and function in patients with CKD. The results will provide valuable insights into the mechanisms underlying the cardioprotective benefits of SGLT2 inhibitors in patients with CKD.

查看译文

关键词

CKD,cardiology,echocardiography,RCT,SGLT2-inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要